Get the Stockscreener App
31.68
0.38%
-0.12
After Hours:
32.00
0.32
+1.01%
Vtv Therapeutics Inc stock is traded at $31.68, with a volume of 17,139.
It is down -0.38% in the last 24 hours and down -19.88% over the past month.
vTv Therapeutics Inc is a late-stage biopharmaceutical company focused on developing oral, small-molecule drug candidates intended to help treat people living with diabetes and other chronic diseases. Its clinical pipeline is led by cadisegliatin (TTP399), a novel, small-molecule, liver-selective glucokinase activator (GKA) currently being evaluated as a potential oral adjunctive therapy to insulin for the treatment of type 1 diabetes (T1D). In addition, the company is also engaged in the research and development of other candidates in its pipeline through collaborations with academic partners and license agreements, which include TTP273, HPP737, TTP-RA, Mavodelpar (HPP593), HPP971, and HPP3033, being studied and developed to counter various chronic diseases.
See More
Previous Close:
$31.80
Open:
$31.71
24h Volume:
17,139
Relative Volume:
0.32
Market Cap:
$124.78M
Revenue:
$17,000
Net Income/Loss:
$-31.08M
P/E Ratio:
-9.4672
EPS:
-3.3463
Net Cash Flow:
$-24.86M
1W Performance:
+1.31%
1M Performance:
-19.88%
6M Performance:
+24.38%
1Y Performance:
+46.13%
1-Day Range:
$31.68
$32.67
1-Week Range:
$30.87
$33.32
52-Week Range:
$14.00
$44.00
Vtv Therapeutics Inc Stock (VTVT) Company Profile
Name
Vtv Therapeutics Inc
Sector
Industry
Phone
336-841-0300
Address
3980 PREMIER DR, HIGH POINT, NC
Compare VTVT vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VTVT
Vtv Therapeutics Inc
|
31.68 | 125.25M | 17,000 | -31.08M | -24.86M | -3.3463 |
VRTX
Vertex Pharmaceuticals Inc
|
427.65 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
721.05 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
807.55 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
303.00 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
313.32 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Vtv Therapeutics Inc Stock (VTVT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-12-26 | Initiated | Evercore ISI | Outperform |
| Jan-23-26 | Initiated | Roth Capital | Buy |
| Jan-05-26 | Initiated | TD Cowen | Buy |
| Nov-19-25 | Initiated | BTIG Research | Buy |
| May-30-19 | Initiated | H.C. Wainwright | Buy |
| Apr-10-18 | Downgrade | Stifel | Buy → Hold |
| Mar-08-18 | Initiated | ROTH Capital | Buy |
| Feb-08-18 | Initiated | Northland Capital | Outperform |
| Sep-26-16 | Initiated | H.C. Wainwright | Buy |
| Sep-04-15 | Initiated | Canaccord Genuity | Buy |
| Aug-24-15 | Initiated | Piper Jaffray | Overweight |
| Aug-24-15 | Initiated | Stifel | Buy |
View All
Vtv Therapeutics Inc Stock (VTVT) Latest News
vTv Therapeutics (NASDAQ:VTVT) Stock Price Passes Below Fifty Day Moving AverageWhat's Next? - MarketBeat
(VTVT) Risk Channels and Responsive Allocation - Stock Traders Daily
MSN Money - MSN
Wall Street analysts think vTv Therapeutics (VTVT) could surge 31.58%: Read this before placing a bet - MSN
vTv Therapeutics (VTVT) Stock: Is It Worth Opening a Position | Q4 2025: Earnings Beat EstimatesSlow Growth - Newser
vTv Therapeutics (NASDAQ: VTVT) details 2026 virtual annual meeting, board and pay - Stock Titan
vTv Therapeutics Inc. (NASDAQ:VTVT) Short Interest Update - MarketBeat
(VTVT) Movement as an Input in Quant Signal Sets - Stock Traders Daily
VTVT (vTv Therapeutics) posts far narrower Q4 2025 loss than expected, yet shares drop six percent today. - Newser
Roth Capital initiates coverage of VTV Therapeutics (VTVT) with buy recommendation - MSN
vTv Therapeutics (NASDAQ:VTVT) Stock Passes Below Fifty Day Moving AverageTime to Sell? - MarketBeat
vTv Therapeutics Inc. delivers 47.7% EPS beat exceeding analyst forecastsPro Trader Recommendations - Cổng thông tin điện tử tỉnh Lào Cai
VTVT vTv Therapeutics posts far narrower Q4 2025 loss than analyst estimates, shares rise modestly.Margin Improvement - Cổng thông tin điện tử tỉnh Tây Ninh
VTVT (vTv Therapeutics Inc.) narrower than expected Q4 2025 loss pushes shares 3.73% higher on upbeat investor sentiment.Crowd Risk Alerts - Xã Châu Thành
Millennium Management LLC Increases Stake in vTv Therapeutics Inc - GuruFocus
Wall Street Analysts See a 39.9% Upside in vTv Therapeutics (VTVT): Can the Stock Really Move This High? - Yahoo Finance
VTVT Forecast, Price Target & Analyst Ratings | VTV THERAPEUTICS INC- CL A (NASDAQ:VTVT) - ChartMill
Millennium entities, Israel A. Englander disclose stakes in vTv Therapeutics (VTVT) - Stock Titan
Short Interest in vTv Therapeutics Inc. (NASDAQ:VTVT) Grows By 24.6% - MarketBeat
vTv Therapeutics Inc. (NASDAQ:VTVT) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Liquidity Mapping Around (VTVT) Price Events - Stock Traders Daily
BTIG reiterates Buy on vTv Therapeutics stock, keeps $49 target By Investing.com - Investing.com Canada
Sentiment Recap: Will vTv Therapeutics Inc outperform the market in YEAR2026 Sector Moves & Weekly Chart Analysis and Guides - baoquankhu1.vn
Investment Review: Will vTv Therapeutics Inc benefit from green energy policiesPortfolio Performance Summary & AI Forecasted Stock Moves - baoquankhu1.vn
BTIG reiterates Buy on vTv Therapeutics stock, keeps $49 target - Investing.com
Published on: 2026-04-11 18:49:35 - baoquankhu1.vn
Market Leaders: Whats next for vTv Therapeutics Inc stock2026 Analyst Calls & Consistent Profit Alerts - baoquankhu1.vn
VTVT Technical Analysis | Trend, Signals & Chart Patterns | VTV THERAPEUTICS INC- CL A (NASDAQ:VTVT) - ChartMill
Aug Shorts: Will vTv Therapeutics Inc face regulatory challengesDividend Hike & Weekly Market Pulse Updates - baoquankhu1.vn
VTV Therapeutics (VTVT) reports $27M 2025 net loss amid cadisegliatin advancements - MSN
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Sahm
New vTv hire gets 4,000 stock options priced at $39.54 - Stock Titan
Growth Recap: Will vTv Therapeutics Inc outperform the market in YEAR2026 Short Interest & Smart Money Movement Tracker - baoquankhu1.vn
We're Not Worried About VTv Therapeutics' (NASDAQ:VTVT) Cash Burn - Moomoo
We Think vTv Therapeutics (NASDAQ:VTVT) Can Easily Afford To Drive Business Growth - Sahm
Why (VTVT) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Wall Street Analysts Think vTv Therapeutics (VTVT) Could Surge 31.58%: Read This Before Placing a Bet - sharewise.com
VTVT SEC FilingsVtv Therapeutics 10-K, 10-Q, 8-K Forms - Stock Titan
Millennium Management LLC Acquires Shares in vTv Therapeutics Inc - GuruFocus
VTVT Stock Analysis: vTv Therapeutics Inc. Biotech Rises 2.19 Percent to 40.53 - Cổng thông tin điện tử tỉnh Lào Cai
VTVT Technical Analysis & Stock Price Forecast - Intellectia AI
Aug PostEarnings: How does vTv Therapeutics Inc score in quality rankingsStop Loss & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
vTv Therapeutics Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
Analysts’ Opinions Are Mixed on These Healthcare Stocks: vTv Therapeutics (VTVT) and CSPC Pharmaceutical Group (OtherCHJTF) - The Globe and Mail
Vtv Therapeutics Inc Stock (VTVT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.77%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):